Abcam provides highly cited antibodies and immunoassay tools for life science research. The company's portfolio includes 37,000 recombinant antibodies and SimpleStep Ignite™ ELISA kits designed for greater sensitivity and broader measuring range.
AI named Abcam from November 2025 to August 2026.
Brand page for abcam-com